Michael_981_8596-600x600

Michael Strübin

Director Digital Health at MedTech Europe

Michael Strübin joined MedTech Europe in September 2018 to help develop the industry’s voice in the digital health field and to represent MedTech Europe’s members vis-à-vis digital health policymakers and stakeholders.

Michael came to us from the Personal Connected Health Alliance (PCHAlliance), an international association of health and technology companies, governments and research organisations to advance personal connected health, where he led European policy and advocacy activities and managed the involvement in EU-funded projects. Before PCHAlliance, he ran the European operations of the Continua Health Alliance, and contributed to other associations in the eHealth field.

Michael’s educational background is in political sciences and humanities, which he studied in Germany and the United States. He spent the first years of his career in the fields of international social development and philanthropy, working in Washington, Warsaw, Berlin and Baltimore. Since 2003 he has been based in Brussels where he lives with his family.

2 blogs from the author

shutterstock_1330315130
Digital

Posted on 24.07.2019

Interoperability unlocks the potential of digital health

Digital health has the potential to make healthcare better for patients and for healthcare professionals, as well as to accelerate the shift towards more efficient and cost-effective ways of delivering care. It promises to make healthcare better, safer, and more centred on the patient. Yet, despite this great potential, the people I speak to – […]

By Michael Strübin Director Digital Health at MedTech Europe

Fotolia_178779357_Subscription_Monthly_M
Digital

Posted on 26.04.2019

Digital health needs incentives

 I’ve always believed that you get what you pay for, and digital health is no exception.  Despite the promises of digital transformation to make healthcare services better, safer and more efficient, analogue healthcare services – visits to the doctor/hospital, therapies and drugs – have proved remarkably resilient.   The reason seems to me quite obvious: analogue […]

By Michael Strübin Director Digital Health at MedTech Europe